Correlation Between Cadrenal Therapeutics, and Immunitybio
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Immunitybio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Immunitybio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Immunitybio, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Immunitybio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Immunitybio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Immunitybio.
Diversification Opportunities for Cadrenal Therapeutics, and Immunitybio
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cadrenal and Immunitybio is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Immunitybio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunitybio and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Immunitybio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunitybio has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Immunitybio go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Immunitybio
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to under-perform the Immunitybio. In addition to that, Cadrenal Therapeutics, is 1.37 times more volatile than Immunitybio. It trades about -0.04 of its total potential returns per unit of risk. Immunitybio is currently generating about -0.01 per unit of volatility. If you would invest 521.00 in Immunitybio on September 1, 2024 and sell it today you would lose (17.00) from holding Immunitybio or give up 3.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Immunitybio
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Immunitybio |
Cadrenal Therapeutics, and Immunitybio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Immunitybio
The main advantage of trading using opposite Cadrenal Therapeutics, and Immunitybio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Immunitybio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunitybio will offset losses from the drop in Immunitybio's long position.The idea behind Cadrenal Therapeutics, Common and Immunitybio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Immunitybio vs. BioLineRx | Immunitybio vs. Ardelyx | Immunitybio vs. Lexicon Pharmaceuticals | Immunitybio vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |